Ginseng (the root of Panax ginseng C. A. MEYER, Araliaceae) is frequently used in Asian countries as a traditional medicine. The major components of ginseng are ginsenosides.
Screening of Bacteria Metabolizing Ginsenoside R c
The bacteria (Bacteroides HJ-15, Bacteroides JY-6, Eubacterium A-44, Bifidobacterium K-110, and Fusobacterium K-60) previously isolated from human intestinal microflora were cultured in 50 ml of tryptic soy broth containing 0.01% sodium thioglycolate and 0.1% ascorbic acid (TSTA), and then each cultured cell was centrifuged at 3000ϫg for 10 min and washed twice with saline.
12) The activities of these collected cells in metabolizing ginsenoside R c were measured using the assay method described.
Metabolism of Ginsenoside R c by Human Intestinal Bacteria and Its Related Antiallergic Activity
Assay of Metabolic Activity of Ginsenoside R c by Human Intestinal Bacteria The reaction mixture containing 100 ml of 1 mM ginsenoside R c and 100 ml of fecal suspension (or bacterial suspension cultured in TSTA broth) was incubated for 12 h at 37°C. The reaction mixture was extracted with ethyl acetate, evaporated, and assayed by TLC: TLC plates, silica gel 60F 254 (Merck Co., U.S.A.); developing solvent, CHCl 3 -MeOH-H 2 O (65 : 35 : 10 v/v, lower phase). The plates were stained by spraying with MeOH-H 2 SO 4 (95 : 5 v/v), followed by heating. The stained TLC plates were then analyzed using a TLC scanner.
Each isolated bacterium was cultured in 50 ml of TSTA broth and centrifuged at 3000ϫg for 30 min. Each collected bacterial pellet was suspended in 50 mM phosphate buffer, pH 7.0, and used as a crude enzyme solution.
Time Course of the Metabolism of Ginsenoside R c by Human Fecal Microflora Ginsenoside R c -metabolizing activity was measured as follows. Two milliliters of fresh human fecal suspension (250 mg/ml) or the isolated intestinal bacterial suspension (250 mg/ml or 1 g/ml) was added to 8 ml of anaerobic diluted medium 9) containing 0.3 mM ginsenoside R c , then incubated at 37°C for 1 d, and an aliquot (0.5 ml) of the reaction mixture was periodically extracted twice with 1 ml of ethyl acetate. The ethyl acetate fraction was analyzed by TLC. Ginsenoside R c and its metabolites were identified by authentic compounds isolated according to our previous method.
The fresh feces of a healthy volunteer (2 g) were collected, suspended in 48 ml of anaerobic dilution medium, centrifuged at 200ϫg for 5 min and the supernatant was centrifuged at 10000ϫg for 30 min.
The isolated bacteria were cultured in 500 ml of TSTA broth, centrifuged at 10000ϫg for 30 min and washed with the anaerobic dilution medium. The fecal and bacterial precipitates (250 mg) were resuspended in 1.75 ml of anaerobic dilution medium.
In Vitro Cytotoxicity Assay The in vitro cytotoxicity was tested against L1210 (mouse lymphocytic leukemia cell line), P388 (mouse lymphoid neoplasma cell line), and A549 (human lung carcinoma) cell lines by MTT [3-(3,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay according to the method of Carmichael et al.
16)

Assay of Antiallergic Activity in RBL-2H3 Cell Line
The inhibitory activity of ginsenosides against the release of b-hexosaminidase from RBL-2H3 cells was evaluated according to Choi et al. 17) RBL-2H3 cells were grown in DMEM supplemented with 10% fetal bovine serum and Lglutamine. Before the experiment, cells were dispensed into 24 well plates at the concentration of 5ϫ10 5 cells per well, using the medium containing 0.5 mg/ml of mouse monoclonal IgE and were incubated overnight at 37°C in 5% CO 2 to sensitize them. The cells were washed with 500 ml of siraganian buffer (pH 7.2, 119 mM NaCl, 5 mM KCl, 0.4 mM MgCl 2 , 25 mM PIPES and 40 mM NaOH) and incubated in 160 ml of siraganian buffer (5.6 mM glucose, 1 mM CaCl 2 , 0.1% BSA were added) for an additional 10 min at 37°C. Then cells were exposed to 40 ml of test materials for 20 min, followed by the treatment with 25 ml of antigen (DNP-BSA, 1 mg/ml) for 10 min at 37°C to activate cells to evoke allergic reactions (degranulations). The reaction was stopped by cooling in an ice bath for 10 min. The reaction mixture was centrifuged and 25 ml aliquots of supernatant were transferred to 96 well plates and incubated with 20 ml of substrate (1 mM p-nitrophenyl-N-acetyl-b-D-glucosaminide) for 1 h at 37°C. The reaction was stopped by adding 0.2 ml of 0.1 N NaOH. The absorbance was measured by ELISA reader at 405 nm.
Nitric Oxide Assay Nitric oxide was determined by measuring the amount of nitrite from cell culture supernatant using the Griess reagent (Promega, U.S.A.) according to the manufacturer's protocol. 18 ) RAW 264.7 cells were stimulated with LPS (1 mg/ml) and test compounds for 24 h. Cells were briefly centrifuged and 150 ml of cell culture supernatant was mixed with 150 ml of Griess reagent, and incubated 5-10 min at room temperature (light protected). The absorbance was measured using an ELISA reader at 540 nm against a calibration curve with sodium nitrate as a standard.
RESULTS
Metabolism of Ginsenoside R c by Human Intestinal Microflora
To investigate the metabolites of ginsenoside R c broken down by human intestinal bacteria, ginsenoside R c was anaerobically incubated for 24 h with a bacterial mixture from human feces. Then the metabolites were extracted with ethyl acetate and analyzed by TLC; six metabolites, three main metabolites and three minor ones, were observed. By analysis of 1 H-and 13 C-NMR spectra, the three main metabolites were identified as ginsenoside Table 1 did not shift upfield compared to that of ginsenoside R c ; however, that of M c did shift upfield. The C-20 signals of ginsenoside R c , M b , and M c remained almost unchanged. These results suggest that the glucosyl moiety of sophorose connected to the C-3 hydroxyl group was hydrolyzed. Therefore, ginsenoside M b was identified as
When the ginsenoside R c -hydrolyzing activity was preliminarily assayed in five human feces, their transforming activities were detected in all specimens, but varied depending on the individual samples. The average of the activities transforming ginsenoside R c to compound K were 0.019Ϯ0.006 mmol/h/mg wet weight of fecal bacteria. When ginsenoside R c was incubated with human intestinal microflora for 24 h, the main metabolites were ginsenoside F 2 and compound K. Other metabolites of ginsenoside R c were ginsenoside M b , ginsenoside R d and 20(S)-protopanaxadiol. When ginsenoside R c was incubated with human fecal microflora, it began to be transformed to ginsenosides R d , M b , M c and F 2 , which were transformed to compound K and 20(S)-protopanaxadiol (Fig. 1) . However, 24 h after incubation the main metabolites were compound K and ginsenoside M c .
When the ginsenoside R c -hydrolyzing bacteria isolated from human fecal microflora were incubated, their metabolic pathways were classified into two groups (Table 2) . One group was the bacteria transforming ginsenoside R c to compound K via ginsenoside R d , such as Bifidobacterium K-103, and the other was the bacteria transforming ginsenoside R c to compound K via ginsenoside M b , such as Bifidobacterium K- The spectra were recorded in pyridine at 500 MHz. Chemicals shift in ppm relative to internal TMS.
Fig. 1. Time Course of Ginsenoside R c Transformation by Human Intestinal Bacteria
The intestinal bacterial suspension was prepared and its metabolites were assayed as described in Materials and Methods. ᭹, ginsenoside R c ; ᭛, ginsenoside R d ; ᭡, ginsenoside M b ; ᭜, ginsenoside M c ; , compound K; ᭺, protopanaxadiol.
506.
Biological Activities of Ginsenoside R c and Its Metabolites The inhibitory effects of ginsenoside R c and its metabolites against tumor cell lines were measured (Table 3) . Compound K and 20(S)-protopanaxadiol showed potent cytotoxicity against tumor cell lines, with IC 50 values of 24-33 and 18-32 mM, respectively; however, new compound ginsenoside M b did not show this inhibitory activity.
The antiallergic activity of ginsenosides was evaluated by its inhibitory activity upon b-hexosaminidase release from RBL-2H3 cells (Table 4) . Ginsenoside R c did not inhibit this release, although its metabolites did inhibit it. Among them, ginsenoside M c and compound K showed the most potent inhibitory activity, with IC 50 values of 30 and 24 mM, respectively. They were more potent than that of DSCG, which is clinically used (IC 50 : 500 mM).
When the murine macrophage cell line RAW 264.7 was incubated with LPS for 24 h, the nitrite content in the media increased four to five-fold. However, when the cells were treated with 1.0 to 100 mM of ginsenosides, ginsenoside M c and compound K for 24 h, the nitrite content was significantly reduced in a dose dependent manner with IC 50 values of 21 and 53 mM, respectively, and that of dexamethasone was observed to be 60 mM.
DISCUSSION
The main components of ginseng, which is frequently used in Asia, are ginsenoside R b1 , R b2 , and R c . To understand what the active compounds of ginsenosides and ginseng extract are when they are orally administered to humans, we measured cytotoxic activities of ginsenoside R c and its metabolites against tumor cell lines. We found that the cytotoxicity of ginsenosides against tumor cell lines was increased when ginsenoside R c was metabolized to compound K or 20(S)-protopanaxdiol by human intestinal microflora. Antiallergic activity was also increased when ginsenoside R c was metabolized to compound K.
Ginsenoside M c and compound K inhibited the release of b-hexosaminidase from RBL-2H3 cells as well as nitric oxide production in LPS-induced RAW 264.7 cells. These results suggested that an antiinflammatory activity of these compounds could be shown to some extent at least by the current bioassay system. Ginsenoside M c and compound K were comparable to quercetin, which is a potent antioxidant, in antiallergic activities. However, compound K did not show the antioxidative activity on the DPPH free radical or superoxide radical generation system. Therefore, the inhibitory mechanism of compound K on nitric oxide production and antiallergy (the release of b-hexosaminidase from RBL-2H3 cells) seems different from that of quercetin (data not shown). So far it is not clear whether the antiinflammatory effect of compound K is associated with the antiallergic effect observed by the inhibitory action on the mast cell degranulation process in vitro. Nevertheless, it seems worthwhile to further investigate the antiallergic and antiinflammatory effect of compound K in detail since this compound possesses both antiallergic and antiinflammatory activities. 746 Vol. 25, No. 6 These results suggest that the natural glycoside ginsenoside R c is a prodrug, which can be transformed to active compounds by intestinal microflora. Finally, we believe that compound K transformed from ginseng saponins can play an important role in antitumor and antiallergic activities.
